Healthcare Financial Management

Every month, hfm shares insights and methods to help organizations cut costs, boost revenue, and handle risks effectively. They offer valuable information tailored for busy CFOs, featuring articles written by leading experts or insights gained from conversations with industry pioneers.

National, Trade/B2B

English

Magazine

Outlet metrics

Domain Authority

Ranking

Global

#241781

United States

#50995

Health/Health

#1140

Traffic sources

Monthly visitors

Articles

Providers, payers both struggle with Medicare Advantage challenges

6 days ago | hfma.org | Nick Hut

Advertisements googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text1' ); } ); googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text2' ); } ); googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text3' ); } ); googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text4' ); } ); googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text5' ); } ); googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text6' ); } );...
HFMA launches FastFinance as a new member benefit for healthcare finance executives

1 week ago | hfma.org | Brad Dennison

In 2024, HFMA’s award-winning editorial team set out to engineer a weekly newsletter product exclusively aimed at busy hospital and health system CFOs. Since launching the pilot in November, it has quickly gained a following among CFOs and other provider executives. In fact, in a recent survey of participating CFOs:91% feel FastFinance is targeted to their interests. 71% say it’s “up to the minute.”91% read every or most editions. 86% say once a week is the right frequency.
Hospitals grapple with uncertain tariff fallout

1 week ago | hfma.org | Nick Hut

Hospitals continue to scramble in response to a shifting tariff policy that has the potential to jolt cost structures. The latest development came May 5, when President Donald Trump signed an executive order to bolster domestic pharmaceutical manufacturing. Among the planned steps is a tariff on pharmaceutical imports, at a rate to be announced within the next two weeks, Trump said.
CFPB no longer supports the final rule on medical debt reporting

1 week ago | hfma.org | Nick Hut

The Consumer Financial Protection Bureau (CFPB) has formally withdrawn its support for a Biden administration rule that would keep medical debt from appearing on consumer credit reports. The rule has been staunchly opposed by the credit-reporting and debt collector industries and also has generated concern among provider advocates who think it could remove an incentive for patients to pay their bills.
What DOGE's actions mean for U.S. healthcare

1 week ago | hfma.org | Erika Grotto

HFMA Senior Editor Rich Daly talks about his ⁠hfm cover story⁠ about DOGE and the healthcare industry. HFMA’s Nick Hut and Shawn Stack talk about the 340B drug pricing program. About the Author is a senior editor at HFMA and is based in Downers Grove, Ill.
Trump proposes big spending cuts to healthcare programs

1 week ago | hfma.org | Nick Hut

President Donald Trump’s FY26 budget proposal includes significant cuts to healthcare programs, but the administration says the reductions will not affect core services. The budget is merely a set of recommendations, given that federal budgetary authority resides with Congress. Trump’s proposals are likely to hold influence with the narrow Republican majorities in both chambers, but much remains to be decided before a final version is passed.
Blue Cross Blue Shield settlement concerns linger

2 weeks ago | hfma.org | Nick Hut

Nearly 15,500 healthcare providers are known to have withdrawn from the record-setting Blue Cross Blue Shield antitrust settlement, retaining the option to pursue separate litigation. The number was listed in an April court filing as the parties move toward a July 29 hearing at which the presiding court is scheduled to consider final approval of the settlement.
Supreme Court: HHS can maintain DSH formula approach that results in lower payments

2 weeks ago | hfma.org | Nick Hut

Advertisements googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text1' ); } ); googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text2' ); } ); googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text3' ); } ); googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text4' ); } ); googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text5' ); } ); googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text6' ); } );...
Upcoming regulations and budget talks could be consequential for Medicaid supplemental payments

2 weeks ago | hfma.org | Nick Hut

The system of directed payment programs (DPPs) has helped make Medicaid more financially viable for providers, but that system is under increasing political pressure. CMS has queued up a proposed rule that is undergoing a standard review at the Office of Management and Budget (OMB) and then is expected to be formally published.
340B changes loom as the program attracts congressional, White House scrutiny

3 weeks ago | hfma.org | Nick Hut

Both Congress and the White House are proposing 340B Drug Pricing Program changes that could add administrative burdens and ultimately limit the available savings for hospitals.